| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5e01baf5bf8afb0b18cc88fdd605d8f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C40B20-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C40B20-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-02 |
| filingDate |
2011-01-18^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c93ab9cdce0506192311ba87b9fce5e |
| publicationDate |
2011-09-01^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2011213135-A1 |
| titleOfInvention |
Cytotoxic Nucleotides for Targeted Therapeutics |
| abstract |
The present invention provides a method of generating a nucleic acid, which specifically binds to an extracellular surface protein expressed by a cell of interest, and which nucleic acid comprises a compound of interest to be delivered to the cell of interest. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10105446-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9486533-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015094359-A1 |
| priorityDate |
2006-02-08^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |